サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1628885

感染症創傷管理の世界市場：製品種類別・治療段階別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Infectious Wound Care Management Market, By Product Type, By Treatment Stage, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 346 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
感染症創傷管理の世界市場：製品種類別・治療段階別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2024年12月02日
発行: AnalystView Market Insights
ページ情報: 英文 346 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

感染症創傷管理の市場規模は2023年に15億2,312万米ドルとなり、2024年から2032年にかけて2.5%のCAGRで拡大

感染症創傷管理の市場力学

慢性疾患の有病率の上昇が高度な感染症創傷管理ソリューションの需要を牽引

感染症創傷管理市場は、糖尿病などの慢性疾患の有病率の上昇により成長を遂げています。糖尿病は世界全体で4億6,000万人以上が罹患しており、慢性創傷や感染症のリスクを高めています。米国疾病予防管理センター (CDC) によると、米国の人口の10%近くが糖尿病を患っており、そのかなりの割合が糖尿病性足潰瘍を発症しているため、専門的な創傷ケア管理が必要です。世界人口の高齢化に伴い、創傷治癒を複雑にする肥満や血管疾患などの症状を持つ人の数も増加しています。抗菌性ドレッシング材、生物学的療法、陰圧創傷治療 (NPWT) などの先進的な創傷ケア製品は、こうした感染症を効果的に管理するために不可欠となっています。さらに、センサー一体型ドレッシング材などのスマート創傷ケアソリューションの技術革新が進み、より個別化された治療オプションが提供され、慢性創傷の治癒時間が短縮されています。

感染症創傷管理市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間 (2024-2032年) に約2.5%のCAGRで毎年成長すると推定されます。

製品種類別では、創傷被覆材が2023年に最大の市場シェアを示すと予測されます。

治療段階別では、2023年には積極的感染治療が主要タイプでした。

地域別では、北米が2023年に主要な収益源となります。

感染症創傷管理市場：セグメンテーション分析

世界の感染症創傷治療管理市場は、製品種類、治療段階、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品種類に基づいて4つのカテゴリーに分けられます：創傷被覆材、創傷洗浄剤、抗菌剤、創傷治癒デバイスです。創傷被覆材は、感染症創傷管理や治癒促進の上で重要な役割を果たすため、市場をリードしています。抗菌剤は、感染制御に対応し、その後に続いています。創傷治癒器具は人気を集めており、創傷洗浄剤は必要不可欠ですが、市場規模は小さいです。

市場は治療段階に基づき3つのカテゴリーに分けられます：予防、積極的感染治療、感染後管理です。積極的感染治療は、創傷の感染症に対処するために極めて重要であるため、優先されます。予防は、傷つきやすい患者の感染リスクを軽減することに重点を置いています。感染後管理は、感染対策後の治癒とリハビリに不可欠であるが、その規模は小さいです。

感染症創傷管理市場：地域別分析

感染症創傷管理市場は、さまざまな地域で多様な成長を示しています。北米、特に米国は糖尿病などの慢性疾患の有病率が高く、創傷ケアソリューションのニーズが高まっているため、大きなシェアを占めています。同地域は高度な医療インフラ、洗練された創傷ケア製品への需要の増加、高齢化人口の増加などの恩恵を受けています。ドイツ、フランス、英国などの国々では慢性創傷の症例が増加しており、感染症創傷管理の需要が高まっています。アジア太平洋地域は、特に中国やインドのような糖尿病やそれに関連する創傷の発生率が上昇傾向にある国々で、医療アクセスの改善により主要市場として急浮上しています。ラテンアメリカと中東・アフリカも、医療投資の増加と創傷ケアソリューションに対する意識の高まりに支えられ、着実な成長が見込まれています。

感染症創傷管理市場：競合情勢

感染症創傷管理市場は競争が激しく、大手企業は革新的な製品開発と戦略的提携に注力しています。主要企業には、スミス・アンド・ネフュー、Molnlycke Health Care、Convatec、3Mなどがあり、抗菌ドレッシング材、陰圧創傷治療 (NPWT)、生物学的創傷治療ソリューションなど、幅広い先進創傷治療製品を提供しています。Molnlycke社のMepilexやSmith &Nephew社のAllevynは、市場で最も売れている製品の一つです。現在3Mの傘下にあるAcelityのような新興企業は、NPWTシステムのような革新的な創傷治癒技術に注力しています。バイオベンタス社やB.ブラウン社も重要なプレーヤーであり、高度な生物学的療法や創傷ケア機器の成長に貢献しています。大企業だけでなく、小規模の専門企業もスマート創傷ケア機器や再生医療ソリューションのような高度でニッチな製品で市場に参入しています。各社は戦略的提携や買収を通じて新興市場でのプレゼンス拡大にも注力しています。

目次

第1章 感染症創傷管理市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 感染症創傷管理の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 感染症創傷管理市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 感染症創傷管理市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 感染症創傷管理の市場情勢

  • 感染症創傷管理の市場シェア分析 (2023年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 感染症創傷管理市場：製品種類別

  • 概要
    • セグメント別シェア分析：製品種類別
    • 創傷被覆材
    • 傷口洗浄剤
    • 抗菌剤
    • 創傷治癒装置

第8章 感染症創傷管理市場：治療段階別

  • 概要
    • セグメント別シェア分析：治療段階別
    • 防止
    • 積極的感染治療
    • 感染後管理

第9章 感染症創傷管理市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院
    • クリニック
    • 外来手術センター (ASC)
    • 在宅医療

第10章 感染症創傷管理市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：感染症創傷管理業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • 3M Company
    • Acelity (KCI Licensing, Inc.)
    • Advanced BioHealing Inc.
    • Aspen Surgical Products
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Coloplast A/S
    • ConvaTec Group PLC
    • Derma Sciences, Inc.
    • Hollister Incorporated
    • Integra LifeSciences Corporation
    • Medline Industries, LP
    • Molnlycke Health Care AB
    • Organogenesis Inc.
    • Smith &Nephew plc
    • Stryker Corporation
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4373

REPORT HIGHLIGHT

Infectious Wound Care Management Market size was valued at USD 1,523.12 Million in 2023, expanding at a CAGR of 2.5% from 2024 to 2032.

The Infectious Wound Care Management Market focuses on treatments and products for managing wounds infected by bacteria, fungi, and other pathogens, aiming to promote healing and prevent complications. With an increasing number of surgical procedures and trauma-related injuries worldwide, the demand for effective wound care products is growing. The World Health Organization (WHO) estimates that approximately 2 million people worldwide suffer from chronic wounds each year, driving the need for advanced infectious wound care solutions. Rising cases of diabetes, obesity, and an ageing population are major contributors to chronic infections that complicate wound healing. However, challenges such as high treatment costs and limited reimbursement options can restrict market growth. Opportunities lie in the development of more effective antimicrobial dressings and biologic products, alongside the integration of advanced technologies like telemedicine and smart wound care systems, which offer faster, more personalized treatments. Increasing healthcare access in emerging markets also opens new avenues for growth.

Infectious Wound Care Management Market- Market Dynamics

Rising Prevalence of Chronic Conditions Drives Demand for Advanced Infectious Wound Care Management Solutions

The Infectious Wound Care Management Market is experiencing growth due to the rising prevalence of chronic conditions such as diabetes, which affects over 460 million people globally, increasing the risk of chronic wounds and infections. According to the Centers for Disease Control and Prevention (CDC), nearly 10% of the U.S. population suffers from diabetes, with a significant proportion developing diabetic foot ulcers, which require specialized wound care management. As the global population ages, the number of individuals with conditions like obesity and vascular diseases, which complicate wound healing, is also rising. Advanced wound care products, including antimicrobial dressings, biologic therapies, and negative pressure wound therapy (NPWT), are becoming essential for managing these infections effectively. Additionally, innovations in smart wound care solutions, such as sensor-integrated dressings, are gaining traction, offering more personalized treatment options and reducing healing time for chronic wounds.

Infectious Wound Care Management Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.5% over the forecast period (2024-2032)

Based on product type segmentation, Wound Dressings was predicted to show maximum market share in the year 2023

Based on Treatment Stage segmentation, Active Infection Treatment was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Infectious Wound Care Management Market- Segmentation Analysis:

The Global Infectious Wound Care Management Market is segmented based on Product Type, Treatment Stage, End-User, and Region.

The market is divided into four categories based on product type: Wound Dressings, Wound Cleansers, Antimicrobial Agents, and Wound Healing Devices. Wound Dressings lead the market due to their critical role in managing infectious wounds and promoting healing. Antimicrobial Agents follow closely, addressing infection control. Wound Healing Devices are gaining popularity, while Wound Cleansers are essential but occupy a smaller segment.

The market is divided into three categories based on Treatment Stage: Prevention, Active Infection Treatment, and Post-Infection Management. Active Infection Treatment takes priority, as it is crucial for addressing infections in wounds. Prevention follows, focusing on reducing infection risks in vulnerable patients. Post-infection management is essential for healing and rehabilitation after infection control, but it is a smaller segment.

Infectious Wound Care Management Market- Geographical Insights

The Infectious Wound Care Management Market exhibits varied growth across different regions. North America, particularly the United States, holds a significant share due to a high prevalence of chronic diseases such as diabetes, which leads to an increased need for wound care solutions. The region benefits from advanced healthcare infrastructure, increasing demand for sophisticated wound care products, and a growing ageing population. Europe follows closely, with countries like Germany, France, and the UK witnessing rising cases of chronic wounds, boosting the demand for infectious wound care management. The Asia-Pacific region is rapidly emerging as a key market, driven by improvements in healthcare access, particularly in countries like China and India, where the incidence of diabetes and related wounds is on the rise. Latin America and Middle East & Africa are also expected to see steady growth, supported by increasing healthcare investments and a growing awareness of wound care solutions.

Infectious Wound Care Management Market- Competitive Landscape:

The Infectious Wound Care Management Market is highly competitive, with leading players focusing on innovative product development and strategic partnerships. Key companies include Smith & Nephew, Molnlycke Health Care, Convatec, and 3M, which offer a wide range of advanced wound care products, including antimicrobial dressings, negative pressure wound therapy (NPWT), and biologic wound care solutions. Molnlycke's Mepilex and Smith & Nephew's Allevyn are among the top-selling products in the market. Newer players like Acelity, now part of 3M, focus on innovative wound-healing technologies, such as NPWT systems. Bioventus and B. Braun are also significant players, contributing to the growth of advanced biological therapies and wound care devices. In addition to large companies, smaller, specialized firms are entering the market with advanced, niche products like smart wound care devices and regenerative medicine solutions. Companies are also focusing on expanding their presence in emerging markets through strategic collaborations and acquisitions.

Recent Developments:

In September 2024, HCAH partnered with Aroa Biosurgery to launch a wound care initiative focused on preventing and treating bedsores. The "WOW Nurses" program emphasizes specialized training for nurses to enhance recovery and reduce complications associated with infectious wounds.

In October 2024, Molnlycke Health Care announced a research collaboration with Transdiagen to enhance infectious wound care management. This partnership aims to utilize novel wound gene signatures for developing innovative treatments, improving understanding and outcomes in chronic wound healing and tissue regeneration.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M Company
  • Acelity (KCI Licensing, Inc.)
  • Advanced BioHealing Inc.
  • Aspen Surgical Products
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Coloplast A/S
  • ConvaTec Group PLC
  • Derma Sciences, Inc.
  • Hollister Incorporated
  • Integra LifeSciences Corporation
  • Medline Industries, LP
  • Molnlycke Health Care AB
  • Organogenesis Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Others

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Wound Dressings
  • Wound Cleansers
  • Antimicrobial Agents
  • Wound Healing Devices

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET, BY TREATMENT STAGE- MARKET ANALYSIS, 2019 - 2032

  • Prevention
  • Active Infection Treatment
  • Post-Infection Management

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Home Healthcare

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Wound Care Management Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Wound Care Management Market Snippet by Product Type
    • 2.1.2. Infectious Wound Care Management Market Snippet by Treatment Stage
    • 2.1.3. Infectious Wound Care Management Market Snippet by End-User
    • 2.1.4. Infectious Wound Care Management Market Snippet by Country
    • 2.1.5. Infectious Wound Care Management Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Wound Care Management Key Market Trends

  • 3.1. Infectious Wound Care Management Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Wound Care Management Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Wound Care Management Market Opportunities
  • 3.4. Infectious Wound Care Management Market Future Trends

4. Infectious Wound Care Management Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Wound Care Management Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Infectious Wound Care Management Market Landscape

  • 6.1. Infectious Wound Care Management Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Wound Care Management Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Wound Dressings
    • 7.1.3. Wound Cleansers
    • 7.1.4. Antimicrobial Agents
    • 7.1.5. Wound Healing Devices

8. Infectious Wound Care Management Market - By Treatment Stage

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Stage, 2023 & 2032 (%)
    • 8.1.2. Prevention
    • 8.1.3. Active Infection Treatment
    • 8.1.4. Post-Infection Management

9. Infectious Wound Care Management Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Ambulatory Surgical Centers (ASCs)
    • 9.1.5. Home Healthcare

10. Infectious Wound Care Management Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Infectious Wound Care Management Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Infectious Wound Care Management Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Infectious Wound Care Management Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Infectious Wound Care Management Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Infectious Wound Care Management Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Infectious Wound Care Management Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. 3M Company
    • 11.2.2. Acelity (KCI Licensing, Inc.)
    • 11.2.3. Advanced BioHealing Inc.
    • 11.2.4. Aspen Surgical Products
    • 11.2.5. B. Braun Melsungen AG
    • 11.2.6. Baxter International Inc.
    • 11.2.7. Coloplast A/S
    • 11.2.8. ConvaTec Group PLC
    • 11.2.9. Derma Sciences, Inc.
    • 11.2.10. Hollister Incorporated
    • 11.2.11. Integra LifeSciences Corporation
    • 11.2.12. Medline Industries, LP
    • 11.2.13. Molnlycke Health Care AB
    • 11.2.14. Organogenesis Inc.
    • 11.2.15. Smith & Nephew plc
    • 11.2.16. Stryker Corporation
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us